Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Prospective Study of Bintrafusp Alfa in Previously Treated Patients With Recurrent and Metastatic (R/M) Non-keratinizing Nasopharyngeal Carcinoma (NPC)

NCT04396886 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04396886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04396886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Prospective Study of Bintrafusp Alfa in Previously Treated Patients With Recurrent and Metastatic (R/M) Non-keratinizing Nasopharyngeal Carcinoma (NPC)
Lead sponsor
The University of Hong Kong
Phase
Phase 2
Overall status
Completed
Start date
February 27, 2020
Completion date
July 26, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, nasopharyngeal carcinoma, non-keratinizing carinoma, recurrent carcinoma